Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, February 22, 2018

Relaxin key to improved stroke rehabilitation outcomes

Has your doctor done ANYTHING AT ALL with this in the past 5.5 years? Or is s/he a stick in the mud with no new knowledge since medical school?
https://www.news-medical.net/news/20120710/Relaxin-key-to-improved-stroke-rehabilitation-outcomes.aspx
Treatment with the reproductive hormone relaxin (RLX) during physical rehabilitative therapy appears to improve long-term outcomes in stroke patients over rehabilitative therapy alone, say researchers.
"Considering the present clinical results and our previous experimental studies, we believe that RLX is a very important, if not the most important, cardiovascular hormone," study author Mario Bigazzi (Prosperius Institute, Florence, Italy), who presented the results at the Endocrinology Society's annual meeting ENDO 2012 in Houston, Texas, USA, told the press.
"We believe that the presence of RLX in women's blood at each ovulation represents the still-undiscovered factor protecting them from cardiovascular diseases during the fertile span of life until the menopause. This may assure their well-known longer survival time than men," he added.
Bigazzi and team enrolled 36 patients aged 64‑79 years who had been admitted to a stroke rehabilitation unit in Italy to take part in their study. The patients were randomly assigned to receive standard poststroke physical rehabilitation plus porcine RLX 40 mg/day (n=18) or physical rehabilitation alone (n=18).
The patients were followed up 20 and 40 days after beginning rehabilitation. There were no physical differences between the groups at 20 days, according to the Functional Independent Measure for daily activity. However, at 40 days the patients in the RLX group achieved a significantly higher score than those in the rehabilitation alone group, at 96 versus 75.
Cognitive function, as assessed by the Trail Making Test, was significantly better in the relaxin compared with the rehabilitation alone group both at 20 (3.5 vs 2.0) and 40 days (4.0 vs 2.0).
Global function, defined according to the modified Rankin Scale, was also significantly improved in the RLX versus the rehabilitation alone group at both 20 and 40 days (2.5 vs 3.0 and 2.0 vs 3.0, respectively).
Discussing the findings, Bigazzi conceded that larger studies are needed, but concluded: "We anticipate that, in the near future RLX, will represent an essential tool in the therapy and primary and secondary prevention of ischemic cardiovascular disease."
Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.
Currently rated 5.0 by 2 people

No comments:

Post a Comment